Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference19 articles.
1. Personalized therapy for lung cancer: striking a moving target;Pakkala;JCI Insight,2018
2. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial;de Langen;Lancet,2023
3. Long-term outcomes and molecular correlates of sotorasib efficacy in patients with pretreated KRAS G12C-mutated non-small-cell lung cancer: 2-year analysis of codebreak 100;Dy;J. Clin. Oncol.,2023
4. T.S. Bekaii-Saab, R. Yaeger, A.I. Spira, M.S. Pelster, J.K. Sabari, N. Hafez, M. Barve, K. Velastegui, X. Yan, A. Shetty, H. Der-Torossian, S. Pant, Adagrasib in advanced solid tumors harboring a KRAS(G12C) mutation, J. Clin. Oncol. doi: 10.1200/jco.23.00434(2023) Jco2300434.
5. Adagrasib in non-small-cell lung cancer harboring a KRAS(G12C) mutation;Jänne;N. Engl. J. Med.,2022
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献